A new implantable brain-stimulating device for patients with hard-to-treat epilepsy has received green signal from the US Food and Drug Administration.
The Neuropace’s RNS Stimulator was cleared by the federal agency to reduce seizures in epilepsy patients who have not responded well to medications.
“The neurostimulator detects abnormal electrical activity in the brain and responds by delivering electrical stimulation intended to normalize brain activity before the patient experiences seizure symptoms,” said Christy Foreman, director of the Office of Device Evaluation in the FDA’s Center for Devices and Radiological Health.
